These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26889194)
1. A novel method for evaluating brain function and microstructural changes in Parkinson's disease. Jiang MF; Shi F; Niu GM; Xie SH; Yu SY Neural Regen Res; 2015 Dec; 10(12):2025-32. PubMed ID: 26889194 [TBL] [Abstract][Full Text] [Related]
2. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease. Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521 [TBL] [Abstract][Full Text] [Related]
3. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease. Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353 [TBL] [Abstract][Full Text] [Related]
6. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease. Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619 [TBL] [Abstract][Full Text] [Related]
8. Microstructural changes in white matter associated with freezing of gait in Parkinson's disease. Vercruysse S; Leunissen I; Vervoort G; Vandenberghe W; Swinnen S; Nieuwboer A Mov Disord; 2015 Apr; 30(4):567-76. PubMed ID: 25640958 [TBL] [Abstract][Full Text] [Related]
9. Diffusion Measure Changes of Substantia Nigra Subregions and the Ventral Tegmental Area in Newly Diagnosed Parkinson's Disease. Shim JH; Baek HM Exp Neurobiol; 2021 Oct; 30(5):365-373. PubMed ID: 34737241 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease. Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007 [TBL] [Abstract][Full Text] [Related]
11. Detecting dopaminergic neuronal degeneration using diffusion tensor imaging in a rotenone-induced rat model of Parkinson's disease: fractional anisotropy and mean diffusivity values. Liu LX; Du D; Zheng T; Fang Y; Chen YS; Yi HL; He QY; Gao DW; Shi QL Neural Regen Res; 2017 Sep; 12(9):1485-1491. PubMed ID: 29089995 [TBL] [Abstract][Full Text] [Related]
12. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra. Joshi N; Rolheiser TM; Fisk JD; McKelvey JR; Schoffer K; Phillips G; Armstrong M; Khan MN; Leslie RA; Rusak B; Robertson HA; Good KP J Neurol; 2017 Jul; 264(7):1497-1505. PubMed ID: 28653210 [TBL] [Abstract][Full Text] [Related]
13. Early limbic microstructural alterations in apathy and depression in de novo Parkinson's disease. Prange S; Metereau E; Maillet A; Lhommée E; Klinger H; Pelissier P; Ibarrola D; Heckemann RA; Castrioto A; Tremblay L; Sgambato V; Broussolle E; Krack P; Thobois S Mov Disord; 2019 Nov; 34(11):1644-1654. PubMed ID: 31309609 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea. Waters CM; Peck R; Rossor M; Reynolds GP; Hunt SP Neuroscience; 1988 May; 25(2):419-38. PubMed ID: 2456487 [TBL] [Abstract][Full Text] [Related]
15. Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies. Salehi MA; Mohammadi S; Gouravani M; Javidi A; Dager SR Hum Brain Mapp; 2022 Dec; 43(18):5658-5680. PubMed ID: 35855597 [TBL] [Abstract][Full Text] [Related]
16. White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations. Agosta F; Kostic VS; Davidovic K; Kresojević N; Sarro L; Svetel M; Stanković I; Comi G; Klein C; Filippi M Mov Disord; 2013 Jun; 28(6):772-8. PubMed ID: 23418083 [TBL] [Abstract][Full Text] [Related]
18. Case control study of diffusion tensor imaging in Parkinson's disease. Chan LL; Rumpel H; Yap K; Lee E; Loo HV; Ho GL; Fook-Chong S; Yuen Y; Tan EK J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1383-6. PubMed ID: 17615165 [TBL] [Abstract][Full Text] [Related]